Method of intravasal dilatation of segmental occlusions of main arteries using new TN-10 mark titanium nickelide construction

A new TN-10 intravasal stent of 20 mark titanium nickelide demonstrated its non-traumaticity, elasticity, biological and biomexhanical compatibility in experimental investigations which were performed on infrarenal aortic segments of 22 animals. Migration and dislocation of the stent were not revealed. Macroand microscopic studies performed demonstrated that neointima forming began by the first month and ended by the sixth month with complete stent endothelization. The implanted stent supports the skeleton thus preventing vascular occlusion development.